VectorY

VectorY Therapeutics

Amsterdam, Netherlands · Founded 2020 · $175.6M raised

Headquarters
Amsterdam
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$175.6M
Last Round
$138.0M Series ANov 2023
Rounds
2

About

VectorY Therapeutics is an Amsterdam-based fully integrated gene therapy company developing vectorized antibody treatments for neurodegenerative diseases including ALS. Founded in August 2020, VectorY combines AAV-based gene therapy with antibody science and operates proprietary R&D and GMP manufacturing facilities at Amsterdam Science Park.

Summary

VectorY is a Life Sciences company based in Amsterdam, Netherlands, founded in 2020. It has raised $175.6M in total across 2 rounds, most recently a $138.0M Series A round in Nov 2023. Investors include Forbion Growth Opportunities Fund, EQT AB and Forbion Capital Partners.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries ANov 2023
$138.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VectorY on Indexed.vc
<a href="https://indexed.vc/companies/vectory"><img src="https://indexed.vc/api/badge/company/vectory" alt="VectorY on Indexed.vc" width="260" height="76" /></a>